Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Chen W, Thomas J, Sadatsafavi M, FitzGerald JM.

Lancet Respir Med. 2015 Jul 21. pii: S2213-2600(15)00241-6. doi: 10.1016/S2213-2600(15)00241-6. [Epub ahead of print]

PMID:
26208998
2.

Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)?

Hirota JA, Carlsten C, Sadatsafavi M, Kaplan G, Hirota SA.

Eur Respir J. 2015 Jul;46(1):287-8. doi: 10.1183/09031936.00003815. No abstract available.

PMID:
26130781
3.

10-Year Trends in Direct Costs of COPD: A Population Based Study.

Khakban A, Sin DD, FitzGerald JM, Ng R, Zafari Z, McManus B, Hollander Z, Marra CA, Sadatsafavi M.

Chest. 2015 Jun 4. doi: 10.1378/chest.15-0721. [Epub ahead of print]

PMID:
26043120
4.

The added effect of comorbidity on health-related quality of life in patients with asthma.

Chen W, Lynd LD, FitzGerald JM, Marra CA, Rousseau R, Sadatsafavi M.

Qual Life Res. 2015 Jun 3. [Epub ahead of print]

PMID:
26038225
5.

COPD: undefeated!

Sadatsafavi M, Sin DD.

Chest. 2015 Apr;147(4):868-9. doi: 10.1378/chest.14-2979. No abstract available.

PMID:
25846522
6.

Interaction effect of psychological distress and asthma control on productivity loss?

Moullec G, FitzGerald JM, Rousseau R, Chen W, Sadatsafavi M; Economic Burden of Asthma (EBA) study team.

Eur Respir J. 2015 Jun;45(6):1557-65. doi: 10.1183/09031936.00141614. Epub 2015 Feb 5.

PMID:
25657023
7.

One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.

Sadatsafavi M, Lynd LD, De Vera MA, Zafari Z, FitzGerald JM.

Respir Med. 2015 Mar;109(3):320-8. doi: 10.1016/j.rmed.2014.12.014. Epub 2015 Jan 7.

PMID:
25596136
8.

Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.

De Vera MA, Sadatsafavi M, Tsao NW, Lynd LD, Lester R, Gastonguay L, Galo J, FitzGerald JM, Brasher P, Marra CA.

Trials. 2014 Dec 13;15:488. doi: 10.1186/1745-6215-15-488.

9.

Exploring the Potential Cost-Effectiveness of Patient Decision Aids for Use in Adults with Obstructive Sleep Apnea: A Case Study.

Trenaman L, Sadatsafavi M, Almeida F, Ayas N, Lynd L, Marra C, Stacey D, Bansback N.

Med Decis Making. 2015 Jul;35(5):671-82. doi: 10.1177/0272989X14556676. Epub 2014 Oct 24.

PMID:
25344130
10.

Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes.

Zafari Z, Thorlund K, FitzGerald JM, Marra CA, Sadatsafavi M.

Pharmacoeconomics. 2014 Oct;32(10):995-1004. doi: 10.1007/s40273-014-0179-1.

PMID:
24920194
11.

Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods.

Sadatsafavi M, Marra C, Aaron S, Bryan S.

Trials. 2014 Jun 3;15:201. doi: 10.1186/1745-6215-15-201.

12.

Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: a simulation study.

Zafari Z, Lynd LD, FitzGerald JM, Sadatsafavi M.

J Allergy Clin Immunol. 2014 Oct;134(4):908-915.e3. doi: 10.1016/j.jaci.2014.04.009. Epub 2014 May 27.

PMID:
24875619
13.

The effect of weekly text-message communication on treatment completion among patients with latent tuberculosis infection: study protocol for a randomised controlled trial (WelTel LTBI).

van der Kop ML, Memetovic J, Patel A, Marra F, Sadatsafavi M, Hajek J, Smillie K, Thabane L, Taylor D, Johnston J, Lester RT.

BMJ Open. 2014 Apr 9;4(4):e004362. doi: 10.1136/bmjopen-2013-004362.

14.

The importance of measuring asthma control in emerging economies.

FitzGerald JM, Sadatsafavi M.

Int J Tuberc Lung Dis. 2014 Mar;18(3):254. doi: 10.5588/ijtld.14.0096. No abstract available.

PMID:
24670557
15.

The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD.

Thorlund K, Zafari Z, Druyts E, Mills EJ, Sadatsafavi M.

Cost Eff Resour Alloc. 2014 Mar 13;12(1):8. doi: 10.1186/1478-7547-12-8.

16.

Heterogeneity's ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations.

Sadatsafavi M, FitzGerald JM.

Thorax. 2014 Nov;69(11):1043-4. doi: 10.1136/thoraxjnl-2013-205061. Epub 2014 Feb 18.

17.

Post-hospital syndrome in adults with asthma: a case-crossover study.

Sadatsafavi M, Lynd LD, Fitzgerald JM.

Allergy Asthma Clin Immunol. 2013 Dec 23;9(1):49. doi: 10.1186/1710-1492-9-49.

18.

The preventable burden of productivity loss due to suboptimal asthma control: a population-based study.

Sadatsafavi M, Rousseau R, Chen W, Zhang W, Lynd L, FitzGerald JM; Economic Burden of Asthma Study Team.

Chest. 2014 Apr;145(4):787-93.

PMID:
24337140
19.

Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.

Sadatsafavi M, Lynd LD, Marra CA, FitzGerald JM.

Thorax. 2014 Apr;69(4):328-34. doi: 10.1136/thoraxjnl-2013-203998. Epub 2013 Nov 26.

PMID:
24281327
20.

Complementary and alternative asthma treatments and their association with asthma control: a population-based study.

Chen W, Fitzgerald JM, Rousseau R, Lynd LD, Tan WC, Sadatsafavi M.

BMJ Open. 2013 Sep 4;3(9):e003360. doi: 10.1136/bmjopen-2013-003360.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk